Stock Events

Stock Events

2seventy bio 

M$170
39
+M$0+0% Wednesday 13:30

Statistics

Day High
170
Day Low
170
52W High
170
52W Low
170
Volume
0
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

6AugExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
-18.79
-9.65
-0.5
8.64
Expected EPS
-2.909775
Actual EPS
N/A

Financials

-146.04%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
697.33MRevenue
-1.02BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TSVT.MX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes in the oncology space, particularly in cell therapies, similar to 2seventy bio's focus on cancer treatments.
Allogene Therapeutics
ALLO
Mkt Cap275.13M
Allogene Therapeutics is involved in the development of allogeneic CAR T therapies for cancer, which is a direct competitor to 2seventy bio's autologous and allogeneic therapy approaches.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is engaged in gene editing and gene-based medicine, competing with 2seventy bio in the innovative therapy space, including cancer treatments.
Novartis
NVS
Mkt Cap237.61B
Novartis is a large pharmaceutical company with a strong presence in the oncology market, including CAR T-cell therapies, competing with 2seventy bio's cancer focus.
Precigen
PGEN
Mkt Cap1.46B
Precigen is a biotechnology company that develops gene and cell therapies, including for oncology, making it a competitor in the advanced therapy market.

About

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Nick Leschly
Employees
437
Country
United States
ISIN
US9013841070

Listings

MX
MX
TSVT.MX

0 Comments

Share your thoughts

FAQ

What is 2seventy bio stock price today?▼
The current price of TSVT.MX is M$170 MXN — it has increased by +0% in the past 24 hours. Watch 2seventy bio stock price performance more closely on the chart.
What is 2seventy bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange 2seventy bio stocks are traded under the ticker TSVT.MX.
What is 2seventy bio revenue for the last year?▼
2seventy bio revenue for the last year amounts to 697.33M MXN.
What is 2seventy bio net income for the last year?▼
TSVT.MX net income for the last year is -1.02B MXN.
How many employees does 2seventy bio have?▼
As of April 01, 2026, the company has 437 employees.
In which sector is 2seventy bio located?▼
2seventy bio operates in the Healthcare sector.
When did 2seventy bio complete a stock split?▼
2seventy bio has not had any recent stock splits.
Where is 2seventy bio headquartered?▼
2seventy bio is headquartered in Cambridge, United States.